全球轴性脊柱关节炎发病年龄:ASAS外周关节受累研究数据
该研究基于24个国家2579例轴性脊柱关节炎(axSpA)患者,评估发病年龄及其与HLA-B27和性别的关系。结果显示92%的患者 axial 症状发病年龄<45岁,各区域间差异小;HLA-B27阳性者和男性发病年龄更早,但男性独立效应仅在亚洲显著。
要点
- 全球92%的axSpA患者 axial 症状发病年龄<45岁,支持该年龄标准跨区域适用。
- HLA-B27阳性患者中位发病年龄25岁,阴性者31岁,阳性者发病更早。
- 男性中位发病年龄25岁,女性28岁,但男性独立效应仅在亚洲有统计学意义。
核心结论
- 全球绝大多数axSpA患者 axial 症状发病年龄<45岁,HLA-B27阳性和男性与更早发病相关。
研究设计与样本
- 对来自全球24个国家、诊断为axSpA且已知 axial 症状发病年龄的患者进行分析。
- 采用累积概率图展示发病年龄累积分布,并建立线性回归模型评估HLA-B27和性别对发病年龄的影响。
主要发现
- 2579例axSpA患者中,92% axial 症状发病年龄<45岁,各区域差异小:亚洲94%(n=574)、欧洲和北美92%(n=988)、拉丁美洲89%(n=246)、中东和北非91%(n=771)。
- HLA-B27阳性患者 axial 症状发病年龄中位数25岁(IQR 19-32),阴性患者31岁(IQR 22-39)。
- 男性 axial 症状发病年龄中位数25岁(IQR 19-33),女性28岁(IQR 21-37)。
- 多变量模型中,独立于HLA-B27的男性性别效应仅在亚洲有统计学显著性。
临床怎么用
- 在全球范围内,可将 axial 症状发病年龄<45岁作为识别axSpA高风险慢性背痛患者的参考标准。
- HLA-B27阳性和男性患者 axial 症状发病更早,临床需关注其早期识别。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: Age at onset is useful in identifying chronic back patients at an increased risk of axial SpA (axSpA). However, the majority of data on which the criterion of age at onset <45 years is based originates from Europe. Therefore it is unknown if this criterion applies in other parts of the world. We aimed to assess the age at onset of axSpA and its relationship with HLA-B27 and gender across the world. METHODS: Analyses were applied to patients from 24 countries across the world with an axSpA diagnosis and known age at onset of axial complaints. Cumulative probability plots were used to display the cumulative distribution of age at onset of axial symptoms. Linear regression models were built to assess the effect of HLA-B27 and gender on age at onset of axial symptoms. RESULTS: Of 2579 axSpA patients, 92% had an age at onset of axial symptoms <45 years, with only small variations across the geographical regions [Asia, n = 574 (94%); Europe and North America, n = 988 (92%); Latin America, n = 246 (89%); Middle East and North Africa, n = 771 (91%)]. Age at onset of axial symptoms was consistently lower in HLA-B27-positive patients {median 25 years [interquartile range (IQR) 19-32] vs 31 [IQR 22-39]} and male patients [median 25 years (IQR 19-33) vs 28 (IQR 21-37)], but in multivariable models an additional statistically significant effect of male gender independent of HLA-B27 was only found in Asia. CONCLUSION: Around the world, the great majority of axSpA patients had an age at onset of axial disease of <45 years, with HLA-B27 and male gender associated with earlier disease onset.
引用
- Boel A, López-Medina C, van der Heijde DMFM, et al. Age at onset in axial spondyloarthritis around the world: data from the Assessment in SpondyloArthritis international Society Peripheral Involvement in Spondyloarthritis study. Rheumatology (Oxford). 2022. PMID: 34260699. doi:10.1093/rheumatology/keab544
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。